Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
about
Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathyExtracellular Superoxide Dismutase Protects against Proteinuric Kidney DiseasePathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.Atrasentan for the treatment of diabetic nephropathy.Keap1 hypomorphism protects against ischemic and obstructive kidney diseaseArrestin(g) podocyte injury with endothelin antagonism.
P2860
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
@ast
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
@en
type
label
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
@ast
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
@en
prefLabel
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
@ast
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
@en
P2093
P2860
P1433
P1476
Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
@en
P2093
Roderick J Tan
Youhua Liu
P2860
P304
P356
10.1371/JOURNAL.PONE.0079963
P407
P577
2013-11-12T00:00:00Z